Shares Investor Evening (Manchester)

Shares Investor Evening (Manchester)

Thursday 10 October 2019
The Shares and AJ Bell Media evening event in Manchester is an opportunity for senior board directors from fast growing listed PLCs to make a presentation about their company and update existing & potential investors on their business plans for 2019.
 
During the event and afterwards over drinks, investors will have the chance to discover new investment opportunities and get to know the companies better by talking one on one with the company directors


Companies presenting:

Amryt Pharma (AMYT) - a revenue-generating orphan drug company focused on acquiring, developing and commercialising products that help improve the lives of patients

Belvoir Group - (BLV) - Belvoir Group is uniquely positioned within the property sector, benefiting from the agility of a franchise business model compared with the larger corporate players, whilst providing our networks with the Central Office systems and support, not available to the smaller independent agents

Open Orphan (ORPH) - a European-focussed, rare and orphan drug consulting services platform. The Company will target the fragmented orphan drug services market in Europe

ReNeuron Group - (RENE) - ReNeuron Group is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.

SkinBioTherapeutics - (SBTX) - SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.The business strategy is to partner and outlicense its programmes at proof of concept.

VolitionRx – (VNRX) - VolitionRx is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present.

 

Who Should Attend

The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.

Evening timings

17.20
Registration and coffee
17.50
Presentations
Kieran Rooney, Vice President - Amryt Pharma (AMYT)
Dorian Gonsalves, CEO - Belvoir Group (BLV)
Cathal Friel, CEO - Open Orphan (ORPH)
Michael Hunt, CFO - ReNeuron Group (RENE)
Stuart Ashman, Chief Executive - SkinBioTherapeutics (SBTX)
Cameron Reynolds, President & CEO - VolitionRx
20.30
Drinks reception and buffet
21.30
Close

Venue

Macdonald Manchester Hotel

Sponsored by

Featured Companies